Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People of any gender
- People who are enrolled in a health insurance plan
- For the lung cancer group: People who have been diagnosed with metastatic stage lung cancer (cancer that has spread), with known mutation status, and who have not yet started treatment
- For the COPD group: People who have been diagnosed with COPD (a chronic lung condition) that developed following smoking
Who may not be able to join:
- People who have tuberculosis or any other active or long-term bacterial infection
- People who have ongoing chronic viral infections, including Hepatitis B, Hepatitis C, or HIV
- People who have previously received or are currently receiving chemotherapy
- People who are not able to be fully informed about the research and give their understanding of it
- People who object to taking part in the research
- People who are currently within an exclusion period from participation in another research study (note: joining an observational study at the same time may be permitted — confirm with trial site)
- People who are pregnant, have recently given birth, or are breastfeeding
- People who are under legal guardianship or a similar form of supervised legal protection
- People who are currently detained or have had their freedom restricted by a legal or administrative decision
- People who receive medical aid coverage under the AME (a specific French state medical assistance program — confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Marie WISLEZ, Pr, Cochin Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP)
Phone: +33 1 58 41 18 89
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Presence of a subpopulation of circulating neutrophils
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.